HeartWare to go OS
Tuesday, 05 August, 2008
Medical device company HeartWare [ASX: HTW] is planning a significant corporate restructuring with the aim of transferring corporate control to the United States.
The plan is for HeartWare, which is developing left ventricular assist devices (LVAD), to effectively swap places with its subsidiary Heartware International. Under the new company structure Heartware International will become the parent company.
All HeartWare shareholders will be given CHESS Depository Interests (CDIs) in Heartware international to the value of their existing shares.
HeartWare will still list on the ASX, but the shares traded under its stock symbol will be HeartWare International shares.
HeartWare representatives say the employees and business goals of the two companies will not change significantly under the new company structure.
Exclusive colostrum intake may reduce risk of food allergies
Newborns who are exclusively fed colostrum in the first 72 hours following birth are five times...
Sunscreen and supplements can lower your vitamin D levels
People who use SPF50+ sunscreen daily are more likely to be vitamin D deficient, while taking...
Low-dose drug prevents diabetes progression in young people
A low dose of the immunomodulatory drug anti-thymocyte globulin (ATG) appears safe and effective...
